Astria Therapeutics Insider Trades

ATXS

Track insider trading activity from Astria Therapeutics executives and directors. See which insiders are buying and selling ATXS stock.

Trades Last 12 Months

ATXS Price

All Insider Trades for Astria Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Komjathy Andrew Chief Commercial Officer
Holding Value $0 0 shares
Last Trade
Jan 23, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$3.52M 280,045 shares
$12.58
$12.58
Violin Jonathan Director
Holding Value $0 0 shares
Last Trade
Jan 23, 2026 Purchase (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$972k 77,249 shares
$12.58
$12.58
Agarwal Sunil Director
Holding Value $0 0 shares
Last Trade
Jan 23, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$321k 28,200 shares
$11.40
$12.58
Bate Kenneth Director
Holding Value $0 0 shares
Last Trade
Jan 23, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$177k 14,100 shares
$12.58
$12.58
Beck Joanne T. Director
Holding Value $0 0 shares
Last Trade
Jan 23, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1M 79,749 shares
$12.58
$12.58
Callori Fred Director
Holding Value $0 0 shares
Last Trade
Jan 23, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$972k 77,249 shares
$12.58
$12.58
Holding Value $0 0 shares
Last Trade
Jan 23, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$334k 26,550 shares
$12.58
$12.58
Holding Value $0 0 shares
Last Trade
Jan 23, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$204k 16,666 shares
$12.24
$12.58
Clauser Noah Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Jan 23, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$3.99M 317,500 shares
$12.58
$12.58
Cole Hugh M Director
Holding Value $0 0 shares
Last Trade
Jan 23, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1M 79,749 shares
$12.58
$12.58
Morabito Christopher Chief Medical Officer
Holding Value $0 0 shares
Last Trade
Jan 23, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$4.31M 342,500 shares
$12.58
$12.58
Milne Jill C. CEO And President
Holding Value $0 0 shares
Last Trade
Jan 23, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$12.1M 960,377 shares
$12.58
$12.58
Matthews Andrea Chief Business Officer
Holding Value $0 0 shares
Last Trade
Jan 23, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$3.97M 315,312 shares
$12.58
$12.58
Harshbarger Benjamin Chief Legal Officer
Holding Value $0 0 shares
Last Trade
Jan 23, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$4.41M 350,833 shares
$12.58
$12.58
Holding Value $61.3M 4,873,721 shares
Last Trade
Feb 01, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$33.6M 2,481,350 shares
$13.56
$12.58
Nichols Andrew John Chief Scientific Officer
Holding Value $692k 55,000 shares
Last Trade
Mar 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$358k 55,000 shares
$6.51
$12.58
Adelman Burt A Director
Holding Value $94.4k 7,500 shares
Last Trade
Jun 11, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$12.58
Donovan Joanne M. Cmo; SVP Clinical Development
Holding Value $755k 60,000 shares
Last Trade
Feb 12, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$12.58
Cunnane Deirdre A. Chief Legal Officer
Holding Value $503k 40,000 shares
Last Trade
Feb 13, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$12.58
Ross Michael Jay Director
Holding Value $176k 14,000 shares
Last Trade
Jun 07, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$12.58

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up